1. Home
  2. PSTV vs LGVN Comparison

PSTV vs LGVN Comparison

Compare PSTV & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • LGVN
  • Stock Information
  • Founded
  • PSTV 1996
  • LGVN 2014
  • Country
  • PSTV United States
  • LGVN United States
  • Employees
  • PSTV N/A
  • LGVN N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • LGVN Medicinal Chemicals and Botanical Products
  • Sector
  • PSTV Health Care
  • LGVN Health Care
  • Exchange
  • PSTV Nasdaq
  • LGVN Nasdaq
  • Market Cap
  • PSTV 8.6M
  • LGVN 7.8M
  • IPO Year
  • PSTV N/A
  • LGVN 2021
  • Fundamental
  • Price
  • PSTV $1.79
  • LGVN $4.37
  • Analyst Decision
  • PSTV Strong Buy
  • LGVN Strong Buy
  • Analyst Count
  • PSTV 1
  • LGVN 1
  • Target Price
  • PSTV $8.00
  • LGVN $12.00
  • AVG Volume (30 Days)
  • PSTV 41.6K
  • LGVN 27.4M
  • Earning Date
  • PSTV 08-12-2024
  • LGVN 08-09-2024
  • Dividend Yield
  • PSTV N/A
  • LGVN N/A
  • EPS Growth
  • PSTV N/A
  • LGVN N/A
  • EPS
  • PSTV N/A
  • LGVN N/A
  • Revenue
  • PSTV $6,084,000.00
  • LGVN $978,000.00
  • Revenue This Year
  • PSTV $5.21
  • LGVN $137.24
  • Revenue Next Year
  • PSTV N/A
  • LGVN $50.77
  • P/E Ratio
  • PSTV N/A
  • LGVN N/A
  • Revenue Growth
  • PSTV 733.42
  • LGVN N/A
  • 52 Week Low
  • PSTV $0.97
  • LGVN $0.77
  • 52 Week High
  • PSTV $3.21
  • LGVN $37.50
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 52.81
  • LGVN 68.96
  • Support Level
  • PSTV $1.40
  • LGVN $3.80
  • Resistance Level
  • PSTV $1.59
  • LGVN $6.40
  • Average True Range (ATR)
  • PSTV 0.15
  • LGVN 0.50
  • MACD
  • PSTV 0.04
  • LGVN 0.25
  • Stochastic Oscillator
  • PSTV 83.03
  • LGVN 49.76

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: